Trades on 1 secondary market

Cardurion Pharmaceuticals

Cardurion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on transforming the treatment of cardiovascular disease and heart failure. Its research and development pipeline centers on novel small-molecule programs including PDE9 inhibition for chronic heart failure (HFrEF and HFp

emerging 15.0 / 100 0 APIs View provider profile →

Company Life Sciences Pharmaceuticals Biotechnology Cardiovascular Heart Failure

Cardurion Pharmaceuticals is an API provider whose private shares are listed on 1 secondary market: Hiive.

Where It Trades

H Hiive View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.